| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 269.51 mm | 269.51 mm | 269.51 mm | 269.51 mm | 269.51 mm | 269.51 mm |
| Cash burn (monthly) | 6.15 mm | (no burn) | 7.30 mm | 6.38 mm | 5.94 mm | 5.20 mm |
| Cash used (since last report) | 8.60 mm | n/a | 10.20 mm | 8.91 mm | 8.30 mm | 7.27 mm |
| Cash remaining | 260.91 mm | n/a | 259.31 mm | 260.60 mm | 261.21 mm | 262.24 mm |
| Runway (months of cash) | 42.4 | n/a | 35.5 | 40.9 | 44.0 | 50.4 |
| 13F holders | Current |
|---|---|
| Total holders | 73 |
| Opened positions | 25 |
| Closed positions | 7 |
| Increased positions | 21 |
| Reduced positions | 15 |
| 13F shares | Current |
|---|---|
| Total value | 353.93 bn |
| Total shares | 10.10 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 1.52 mm | $70.01 bn |
| Mcguire Terrance | 1.07 mm | $1.50 mm |
| Vida Ventures II | 1.03 mm | $1.44 mm |
| Vida Ventures Advisors | 1.03 mm | $47.49 bn |
| EcoR1 Capital | 849.14 k | $39.20 bn |
| Farallon Capital Management | 713.05 k | $32.92 bn |
| 5AM Venture Management | 596.66 k | $27.55 bn |
| Paradigm Biocapital Advisors | 485.11 k | $22.40 bn |
| Vanguard | 361.05 k | $16.67 bn |
| Timothy A Springer | 310.22 k | $10.96 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 25 Sep 25 | Marc Schwabish | Common Stock | Grant | Acquire A | No | No | 0 | 4,210 | 0.00 | 22,933 |
| 25 Sep 25 | Marc Schwabish | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 14.71 | 7,650 | 112.53 k | 7,650 |
| 25 Sep 25 | Peter McNamara | Common Stock | Grant | Acquire A | No | No | 0 | 4,550 | 0.00 | 33,879 |
| 25 Sep 25 | Peter McNamara | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 14.71 | 8,260 | 121.50 k | 8,260 |
| 25 Sep 25 | Daniel Lochner | Common Stock | Grant | Acquire A | No | No | 0 | 5,430 | 0.00 | 28,121 |
| 25 Sep 25 | Daniel Lochner | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 14.71 | 9,860 | 145.04 k | 9,860 |
| 25 Sep 25 | Marcella K. Ruddy | Common Stock | Grant | Acquire A | No | No | 0 | 5,370 | 0.00 | 55,311 |
| 25 Sep 25 | Marcella K. Ruddy | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 14.71 | 9,750 | 143.42 k | 9,750 |
| 25 Sep 25 | Reicin Alise | Common Stock | Grant | Acquire A | No | No | 0 | 14,700 | 0.00 | 228,185 |
| 25 Sep 25 | Reicin Alise | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 14.71 | 26,710 | 392.90 k | 26,710 |
